Literature DB >> 6404828

Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

A T Hastie, S T Hingley, F Kueppers, M L Higgins, C S Tannenbaum, G Weinbaum.   

Abstract

The temporal appearance of extracellular proteases produced by Pseudomonas aeruginosa was analyzed by pH 9 and pH 4 polyacrylamide gel electrophoresis (PAGE) and sodium dodecyl sulfate-PAGE. Ammonium sulfate precipitates of culture supernatants from various stages of growth revealed a time-dependent increase in number and amount of proteolytically active proteins. One mucoid P. aeruginosa clinical isolate and its derived nonmucoid variant, as well as two other nonmucoid variant P. aeruginosa strains (all from cystic fibrosis patients), showed similar production of five differently migrating proteases (P1 to P5, numbered according to increasing net negative charge) in pH 9 PAGE and one protease in pH 4 PAGE. P2, P3, and P5 increased to maximum concentrations at 24 to 48 h, decreasing thereafter, whereas P4 continued increasing even at 83 h, and P1 fluctuated. P3 was identified as an elastase. P2 was possibly composed of polypeptide chains bridged by disulfide bonds, since without reduction it migrated in sodium dodecyl sulfate-PAGE as a single protein, and with reduction it migrated as three protein bands. Two-dimensional PAGE revealed multiple molecular weight species within protease-positive bands in pH 9 gel strips. Isoelectric focusing gave a pattern of protein separation that correlated with two-dimensional PAGE analysis. Thus, greater heterogeneity of active proteases than previously reported has been demonstrated in all P. aeruginosa clinical isolates studied by sensitive two-dimensional PAGE analysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404828      PMCID: PMC264884          DOI: 10.1128/iai.40.2.506-513.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  ESTIMATION OF ELASTOLYTIC ACTIVITY OF STRAINS OF PSEUDOMONAS AERUGINOSA.

Authors:  J D MULL; W S CALLAHAN
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

3.  Nutritional factors controlling exocellular protease production by Pseudomonas aeruginosa.

Authors:  S E Jensen; I T Fecycz; J N Campbell
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

4.  Pseudomonas colonization in cystic fibrosis. A study of 160 patients.

Authors:  L L Kulczycki; T M Murphy; J A Bellanti
Journal:  JAMA       Date:  1978-07-07       Impact factor: 56.272

5.  Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.

Authors:  J Y Homma; C Abe; K Tanamoto; Y Hirao; K Morihara; H Tsuzuki; R Yanagawa; E Honda; Y Aoi; Y Fujimoto; M Goryo; N Imazeki; H Noda; A Goda; S Takeuchi; T Ishihara
Journal:  Jpn J Exp Med       Date:  1978-04

6.  Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families.

Authors:  L R Laraya-Cuasay; K R Cundy; N N Huang
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

7.  Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool.

Authors:  J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

8.  Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.

Authors:  D E Ohman; S J Cryz; B H Iglewski
Journal:  J Bacteriol       Date:  1980-06       Impact factor: 3.490

9.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

View more
  8 in total

1.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

2.  Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins; G Weinbaum; T Shryock
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.

Authors:  D J Thornton; J K Sheehan; H Lindgren; I Carlstedt
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

Review 4.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].

Authors:  U Winkler; J Wingender; K E Jäger
Journal:  Klin Wochenschr       Date:  1985-06-03

6.  Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

7.  Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.

Authors:  M A Luzar; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Authors:  A E Hollsing; M Granström; M L Vasil; B Wretlind; B Strandvik
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 11.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.